Morning Overview on MSN
Japanese researchers just built vitamin K-based compounds that make the brain grow lost neurons again — aimed straight at Alzheimer’s and Parkinson’s
Vitamin K is best known for helping blood clot. A research team at Shibaura Institute of Technology in Tokyo is now trying to turn it into something far more ambitious: a molecular scaffold that ...
Treatment for diabetes and obesity is rapidly evolving, with multi-targeted approaches taking shape. Medications like semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, have set high ...
Artificial intelligence (AI) has identified two plant-based bioactive compounds with potential as glucagon-like-peptide-1 receptor (GLP-1R) agonists for weight loss as possible alternatives to ...
Hosted on MSN
Scientists develop quintuple agonists, a promising new treatment for diabetes and obesity
In recent years, a new class of incretin drugs that includes glucagon-like-peptide-1 inhibitors (single agonists such as semaglutide) and also dual glucose-dependent insulinotropic polypeptide (GIP) ...
Opioid agonists are substances that activate opioid receptors in the central and peripheral nervous systems. They have several uses, from pain management to treating opioid use disorder. You have ...
In a recent study published in the journal Science Advances, researchers in Sweden conducted virtual screens of over 16 million compounds using multiple receptor models developed by AlphaFold and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results